Published Date: 10 Mar 2023
Nearly two dozen clinical trials targeting the immune system are in clinical trials for Alzheimer's disease.
Read Full NewsOcular motor cranial neuropathy is associated with an increased risk for Parkinson’s disease, a new study shows.
Traumatic brain injury is bidirectionally associated with the incidence of stroke, dementia, epilepsy, and Parkinson’s disease, a retrospective study shows.
A large database study found overall 5- and 10-year improvement in pediatric cancer survival, but some cancers lag others, and demographic factors seem to influence trends.
Workforce projections show an uneven distribution of rheumatologists in the US, with notable shortages in nonmetropolitan areas and certain states and districts.
A phase 2 trial assesses fixed-duration epcoritamab monotherapy as first-line therapy for frail older adults with newly diagnosed anthracycline-ineligible large B-cell lymphoma.
All adults aged 65-74 with a chronic respiratory condition or a weakened immune system will be offered the RSV vaccine from September, NHS England has confirmed.
Emerging evidence suggests coffee influences gut microbiota through bioactive compounds beyond caffeine, with potential effects on digestive and metabolic health.
1.
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment
2.
Prostate cancer screening program beneficial in top decile of polygenic risk score
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
King Charles' Cancer; COVID Vax Now or Later; Was RFK Jr. a Drug Dealer?
5.
Obesity-associated cancers may be on the rise in Puerto Rico
1.
A New Perspective on Spherocytosis: Uncovering Innovative Treatments
2.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
3.
Unlocking the Secrets of Improved Ovarian Cancer Survival Rates
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Essential Applications in Oncology in Daily Practice
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation